BACKGROUND: A cohort of 211 factory workers was exposed to a point source of Q fever in 2002. A total of 38 cases and 14 controls took part in a follow-up study 6 years after the outbreak. AIM: To compare Q fever serology, the presence of viable Coxiella burnetii, its DNA and fatigue between patients and controls. DESIGN: Laboratory case study. METHODS: Q fever serology was by microimmunofluroescence. Viable C. burnetii was detected by VERO cell culture and SCID mice inoculation with patient blood samples. Coxiella burnetii DNA was detected by qPCR (com1 gene) on patients' PBMC and on VERO cultures after 6 weeks incubation. Fatigue was measured by the Chalder Fatigue Scale. RESULT: At 6 years after the outbreak, 7 of the 38 patients had become seronegative and 4 of the 14 of the controls had become seropositive for Q fever. None of the patient/control peripheral blood mononuclear cells (PBMC) contained viable C. burnetii by VERO cell culture or by SCID mouse inoculation (death or splenomegaly) and none contained C. burnetii DNA by qPCR. CONCLUSION: Six years after acute Q fever, some patients had become seronegative but none contained viable C. burnetii or its DNA in their PBMC.
BACKGROUND: A cohort of 211 factory workers was exposed to a point source of Q fever in 2002. A total of 38 cases and 14 controls took part in a follow-up study 6 years after the outbreak. AIM: To compare Q fever serology, the presence of viable Coxiella burnetii, its DNA and fatigue between patients and controls. DESIGN: Laboratory case study. METHODS: Q fever serology was by microimmunofluroescence. Viable C. burnetii was detected by VERO cell culture and SCIDmice inoculation with patient blood samples. Coxiella burnetii DNA was detected by qPCR (com1 gene) on patients' PBMC and on VERO cultures after 6 weeks incubation. Fatigue was measured by the Chalder Fatigue Scale. RESULT: At 6 years after the outbreak, 7 of the 38 patients had become seronegative and 4 of the 14 of the controls had become seropositive for Q fever. None of the patient/control peripheral blood mononuclear cells (PBMC) contained viable C. burnetii by VERO cell culture or by SCIDmouse inoculation (death or splenomegaly) and none contained C. burnetii DNA by qPCR. CONCLUSION: Six years after acute Q fever, some patients had become seronegative but none contained viable C. burnetii or its DNA in their PBMC.
Authors: Gabriëlla Morroy; Wim van der Hoek; Jelle Albers; Roel A Coutinho; Chantal P Bleeker-Rovers; Peter M Schneeberger Journal: PLoS One Date: 2015-07-01 Impact factor: 3.240
Authors: Gabriella Morroy; Stephan P Keijmel; Corine E Delsing; Gijs Bleijenberg; Miranda Langendam; Aura Timen; Chantal P Bleeker-Rovers Journal: PLoS One Date: 2016-05-25 Impact factor: 3.240
Authors: Anja Scholzen; Margot de Vries; Hans-Peter Duerr; Hendrik-Jan Roest; Ann E Sluder; Mark C Poznansky; Milou L C E Kouwijzer; Anja Garritsen Journal: Front Immunol Date: 2021-07-28 Impact factor: 7.561
Authors: Jesper M Weehuizen; Rik van Spronsen; Andy I M Hoepelman; Chantal P Bleeker-Rovers; Jan Jelrik Oosterheert; Peter C Wever Journal: J Clin Med Date: 2022-01-20 Impact factor: 4.241
Authors: M M A De Lange; B Schimmer; P Vellema; J L A Hautvast; P M Schneeberger; Y T H P Van Duijnhoven Journal: Epidemiol Infect Date: 2013-08-07 Impact factor: 2.451
Authors: Roan Pijnacker; Johan Reimerink; Lidwien A M Smit; Arianne B van Gageldonk-Lafeber; Jan-Paul Zock; Floor Borlée; Joris Yzermans; Dick J J Heederik; Catharina B M Maassen; Wim van der Hoek Journal: BMC Infect Dis Date: 2017-11-21 Impact factor: 3.090
Authors: P M Reeves; S Raju Paul; L Baeten; S E Korek; Y Yi; J Hess; D Sobell; A Scholzen; A Garritsen; A S De Groot; L Moise; T Brauns; R Bowen; A E Sluder; M C Poznansky Journal: Sci Rep Date: 2020-08-07 Impact factor: 4.379